OAC
IDXX icon

OMERS Administration Corp’s Idexx Laboratories IDXX Stock Holding History

OMERS Administration Corp’s Portfolio IDXX Stock Details IDXX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$7.04M Buy
13,373
+1,362
+11% +$764K 0.04% 230
2026
Q1 		$6.75M Buy
12,011
+5,628
+88% +$3.61M 0.04% 193
2025
Q4 		$4.32M Hold
6,383
– – 0.03% 201
2025
Q3 		$4.08M Sell
6,383
-600
-9% -$364K 0.03% 217
2025
Q2 		$3.75M Sell
6,983
-500
-7% -$239K 0.03% 207
2025
Q1 		$3.14M Buy
7,483
+603
+9% +$262K 0.03% 237
2024
Q4 		$2.84M Buy
6,880
+389
+6% +$171K 0.02% 241
2024
Q3 		$3.28M Sell
6,491
-700
-10% -$340K 0.03% 240
2024
Q2 		$3.5M Buy
+7,191
New +$3.61M 0.03% 211
2020
Q1 		– Sell
-26,700
Closed -$6.97M – 282
2019
Q4 		$6.97M Sell
26,700
-2,000
-7% -$527K 0.08% 143
2019
Q3 		$7.8M Buy
28,700
+6,400
+29% +$1.78M 0.08% 155
2019
Q2 		$6.22M Buy
22,300
+19,700
+758% +$4.85M 0.06% 165
2019
Q1 		$602K Buy
+2,600
New +$537K 0.01% 260
2018
Q1 		– Sell
-19,100
Closed -$2.99M – 462
2017
Q4 		$2.99M Sell
19,100
-5,300
-22% -$834K 0.03% 209
2017
Q3 		$3.79M Buy
+24,400
New +$3.86M 0.04% 179
2016
Q4 		– Sell
-14,300
Closed -$1.61M – 426
2016
Q3 		$1.61M Sell
14,300
-32,600
-70% -$3.44M 0.03% 279
2016
Q2 		$4.36M Sell
46,900
-1,700
-3% -$146K 0.09% 155
2016
Q1 		$3.81M Sell
48,600
-104,700
-68% -$7.54M 0.08% 153
2015
Q4 		$11.2M Sell
153,300
-2,800
-2% -$200K 0.29% 75
2015
Q3 		$11.6M Sell
156,100
-1,600
-1% -$115K 0.34% 77
2015
Q2 		$10.1M Buy
157,700
+14,100
+10% +$976K 0.4% 71
2015
Q1 		$11.1M Buy
143,600
+9,800
+7% +$763K 0.42% 66
2014
Q4 		$9.92M Buy
133,800
+85,400
+176% +$5.99M 0.3% 80
2014
Q3 		$2.85M Buy
+48,400
New +$3.06M 0.09% 142
2014
Q2 		– Sell
-24,200
Closed -$1.47M – 408
2014
Q1 		$1.47M Buy
+24,200
New +$1.44M 0.05% 161

Other funds holding IDXX

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.26T AUM 61.52% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
BAMCO Inc
BAMCO Inc New York $66.6B AUM 7.35% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $609B AUM 40.19% 1-Year Est. Return
Arrowstreet Capital
Arrowstreet Capital Boston, Massachusetts $225B AUM 49.49% 1-Year Est. Return

OMERS Administration Corp's IDXX Position: Q2 2026 in Review

OMERS Administration Corp increased its Idexx Laboratories (IDXX) stake by 11% in Q2 2026, buying an estimated $764K and bringing the position to 13,373 shares worth $7.04M. The position accounts for 0.04% of the portfolio, ranked #230.

OMERS Administration Corp first reported a position in IDXX in Q1 2014 and has held it in 25 quarters since. The position peaked at $11.6M in Q3 2015. 1,302 funds tracked by Wall St. Rank hold IDXX as of Q2 2026.

  • OMERS Administration Corp held 13,373 shares of Idexx Laboratories worth $7.04M as of Q2 2026.
  • OMERS Administration Corp bought 1,362 Idexx Laboratories shares in Q2 2026, an estimated $764K.
  • Idexx Laboratories made up 0.04% of OMERS Administration Corp's portfolio in Q2 2026, its #230 holding.
  • OMERS Administration Corp first reported a position in Idexx Laboratories in Q1 2014 and has held it in 25 quarters since.
  • OMERS Administration Corp's Idexx Laboratories position peaked at $11.6M in Q3 2015.
  • 1,302 funds tracked by Wall St. Rank held Idexx Laboratories as of Q2 2026.

Based on OMERS Administration Corp's 13F filing for Q2 2026, filed 13 Aug 2026.